Videos / Updated indications for the recombinant, adjuvanted RSV vaccine
In this Product Explainer Cardiologist Prof Andrew Sindone provides an update on a recombinant, adjuvanted respiratory syncytial virus (RSV) vaccine.
This educational video was developed by Healthed in collaboration with and with funding from GSK.
Views of the speaker are their own and do not necessarily reflect that of GSK. GSK recommends usage in accordance with the Product Information.
PM-AU-RSA-WCNT-250023. Date of approval: May 2025.
Acutely Painful Shoulder – Assessment and Management in GP
Chronic Kidney Disease – Delay Progression and Prevent Dialysis
Understand & Explain the Risks & Side Effects of MHT
Invasive Pneumococcal Disease – What GPs Need to Know
expert
Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital; Head, Department of Cardiology, Ryde Hospital